An interventional study of Conventional rehabilitation will be applied and Mirror therapy will be applied along with conventional rehabilitation in Stroke, Mirror Movement Therapy and Rehabilitation, sponsored by Ataturk University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-20.
Sponsored by Ataturk University · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 487 studies in Stroke with a site in Turkey — 96 open to participants now, 109 under way, 3 of them phase 3. Stroke · Turkey.
Among the 487 studies in Stroke with a site in Turkey, this one is the 88th largest by enrollment of the 323 interventional ones that give a count, is one of 64 that started in 2024, is one of 294 with no phase, and was the 327th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →96 of the 487 studies in Stroke with a site in Turkey are open now. Recruiting first, the newest first:
Izmir City Hospital · Sites in Turkey
Ages 18–90
Izmir City Hospital · Sites in Turkey
Ages 18–90
Istanbul University - Cerrahpasa · Sites in Turkey
Ages 18–75
Bitlis Eren University · Sites in Turkey
Ages 18–75
Istinye University · Sites in Turkey
Ages 40–70
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
487 studies; the count open now beside each. This study's row is marked.
First in 1998; this study’s year is marked. 64 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 56 is above the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 40 across the 323 interventional studies, 63 across the 164 observational. Of the 339 that completed or were terminated, 22 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
29 of 487 have an industry lead sponsor. The 10 most frequent:
Ataturk University is the lead sponsor of 463 studies on the registry; 123 are open to participants now.
Ataturk University has 4 studies filed under Stroke — fewer than ten, so there is no comparison to draw.
36 of the studies in Stroke with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07551141Bitlis Eren UniversityEffects of Plantar Vibration on Gait and Balance in Stroke | 2026-11 |
| NCT07550270Gaziler Physical Medicine and Rehabilitation Education and Research HospitalBody Weight-Supported and Virtual Reality Gait Training in Stroke Patients | 2026-11 |
| NCT07948187Nour ABDULRAHIM ALMNLAMirror Therapy With Olfactory-Motor Priming for Arm Recovery After Stroke | 2026-11-22 |
| NCT06166862Karamanoğlu Mehmetbey UniversityAction Observation and Motor Imagery Therapy in Stroke | 2026-12 |
| NCT07822854Nermin KARTVagal Stimulation in Individuals With Stroke | 2026-12-01 |
Add all 36 to your calendar (.ics) → With an account.
Among the 487 studies in Stroke with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Purpose: The research will be conducted to evaluate the effect of Mirror Therapy applied to Stroke Patients on motor-sensory status and quality of life.
Method: The research will be carried out as a randomized controlled experimental study at Bilecik Training and Research Hospital and Bozüyük State Hospital between 01.08.2024-01.05.2025. The population of the research consists of 350 people. Individuals will be distributed to the experimental (30) and control (30) groups by simple randomization method. In collecting research data; The patient introduction form, Brunnstrom Staging and SF-36 Quality of Life Scale will be administered to the patients in both groups by the researcher using face-to-face interview technique (pre-test). Patients in the experimental group will be informed about mirror therapy.
In addition to conventional rehabilitation, patients in the experimental group will receive mirror therapy for 30 minutes, 4 times a week for 4 weeks.
Patients in the control group will only receive conventional rehabilitation for 30 minutes, 4 times a week for 4 weeks. At the end of the 4th week, patients in both groups will be administered Brunnstrom Staging and SF-36 Quality of Life Scale (posttest).
If both groups are discharged before 4 weeks, the planned practices will continue at home.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Behavioral: Conventional rehabilitation will be applied
Behavioral: Mirror therapy will be applied along with conventional rehabilitation
Conventional rehabilitation will be applied for 30 minutes, 4 times a week for 4 weeks.
In addition to conventional rehabilitation, patients in the experimental group will receive mirror therapy for 30 minutes, 4 times a week for 4 weeks.
Brunnstrom Motor-Sensory Staging
Brunnstrom staging, which divides the motor recovery process in hemiplegic patients into 6 periods, was used in the upper extremity motor-sensory evaluation of the patients. Brunnstrom staging; Reveals the stages of recovery of patients from hemiplegia after a stroke. It was developed by Swedish physiatrist Signe Brunnström and highlights the synergistic pattern that develops during recovery from stroke.
Time frame: 1 month
SF-36 Quality of Life Scale
The SF-36 quality of life scale was used to determine the patients' quality of life. The scale was developed by Ware and Sherbourne in 1992. The validity and reliability of the scale in Turkish was conducted by Koçyiğit. Quality of life scale; It contains 36 statements evaluating 2 main dimensions and 8 sub-dimensions. The scale has Likert type scoring. 35 of the 36 statements in the scale are evaluated considering the last 4 weeks.
Time frame: 1 month
Ran from Aug 2024 to primary completion in May 2025, 9 months.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's 9 months is below that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 20, 2026: start May 2025 → Aug 2024, primary completion Jan 2026 → May 2025 and completion Jan 2026 → May 2025.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.